Takashi Ishida

20PUBLICATIONS
40CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Aircraft performance and flight control systemsHaematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 15, 2025
A phase 2 trial of CHOP with anti-CCR4 antibody mogamulizumab for older patients with adult T-cell leukemia/lymphoma.

Makoto Yoshimitsu, Ilseung Choi, Shigeru Kusumoto

|Oct 20, 2023
Clinical landscape of TP73 structural variants in ATL patients.

Hiroaki Hiramatsu, Rui Yokomori, Liu Shengyi

|May 05, 2023
The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axis.

Kazuaki Kameda, Ryo Yanagiya, Yuji Miyatake

|Aug 31, 2022
CCR7 alterations associated with inferior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment.

Yuma Sakamoto, Takashi Ishida, Ayako Masaki

|Jul 30, 2022
Requirement for TP73 and genetic alterations originating from its intragenic super-enhancer in adult T-cell leukemia.

Jolynn Zu Lin Ong, Rui Yokomori, Regina Wan Ju Wong

|Nov 05, 2021
Clinicopathological significance of CD28 overexpression in adult T-cell leukemia/lymphoma.

Yuma Sakamoto, Takashi Ishida, Ayako Masaki

Pageof 4

Frequent Collaborators

5 joint publications

Hiroshi Inagaki

4 joint publications

Nobuaki Nakano

4 joint publications

Kisato Nosaka

4 joint publications

Shinsuke Iida